These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16267338)

  • 1. A Weight-of-evidence analysis of the cancer dose-response characteristics of 2,3,7,8-tetrachlorodibenzodioxin (TCDD).
    Popp JA; Crouch E; McConnell EE
    Toxicol Sci; 2006 Feb; 89(2):361-9. PubMed ID: 16267338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD).
    Gaylor DW; Aylward LL
    Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk ranges for various endpoints following exposure to 2,3,7,8-TCDD.
    Portier C
    Food Addit Contam; 2000 Apr; 17(4):335-46. PubMed ID: 10912247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in acute toxicity syndromes of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in rats.
    Niittynen M; Simanainen U; Syrjälä P; Pohjanvirta R; Viluksela M; Tuomisto J; Tuomisto JT
    Toxicology; 2007 Jun; 235(1-2):39-51. PubMed ID: 17448584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the translation of uncertainty from toxicokinetic to toxicodynamic models--the TCDD example.
    Heinzl H; Mittlböck M; Edler L
    Chemosphere; 2007 Apr; 67(9):S365-74. PubMed ID: 17224175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCDD exposure-response analysis and risk assessment.
    Cheng H; Aylward L; Beall C; Starr TB; Brunet RC; Carrier G; Delzell E
    Risk Anal; 2006 Aug; 26(4):1059-71. PubMed ID: 16948697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates of cancer potency of 2,3,7,8-tetrachlorodibenzo(p)dioxin using linear and nonlinear dose-response modeling and toxicokinetics.
    Simon T; Aylward LL; Kirman CR; Rowlands JC; Budinsky RA
    Toxicol Sci; 2009 Dec; 112(2):490-506. PubMed ID: 19776211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice.
    Wyde ME; Braen AP; Hejtmancik M; Johnson JD; Toft JD; Blake JC; Cooper SD; Mahler J; Vallant M; Bucher JR; Walker NJ
    Toxicol Sci; 2004 Nov; 82(1):34-45. PubMed ID: 15282402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCDD and cancer: a critical review of epidemiologic studies.
    Boffetta P; Mundt KA; Adami HO; Cole P; Mandel JS
    Crit Rev Toxicol; 2011 Aug; 41(7):622-36. PubMed ID: 21718216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative relationship of dioxin-responsive gene expression to dioxin response element in Hep3B and HepG2 human hepatocarcinoma cell lines.
    Kim WK; In YJ; Kim JH; Cho HJ; Kim JH; Kang S; Lee CY; Lee SC
    Toxicol Lett; 2006 Aug; 165(2):174-81. PubMed ID: 16697128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian tumors in rats induced by chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment.
    Davis BJ; Mccurdy EA; Miller BD; Lucier GW; Tritscher AM
    Cancer Res; 2000 Oct; 60(19):5414-9. PubMed ID: 11034082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health risks of "dioxins": a review of environmental and toxicological considerations.
    Dickson LC; Buzik SC
    Vet Hum Toxicol; 1993 Feb; 35(1):68-77. PubMed ID: 8434461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
    Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical view of the mechanism(s) of toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Implications for human safety assessment.
    Rozman K
    Derm Beruf Umwelt; 1989; 37(3):81-92. PubMed ID: 2663408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessments of polychlorinated dibenzo- p-dioxins, polychlorinated dibenzofurans, and dioxin-like polychlorinated biphenyls in food.
    Larsen JC
    Mol Nutr Food Res; 2006 Oct; 50(10):885-96. PubMed ID: 17009211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basis for a proposed reference dose (RfD) for dioxin of 1-10 pg/kg-day: a weight of evidence evaluation of the human and animal studies.
    Greene JF; Hays S; Paustenbach D
    J Toxicol Environ Health B Crit Rev; 2003; 6(2):115-59. PubMed ID: 12554432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology reevaluation of the Kociba et al. (1978) bioassay of 2,3,7,8-TCDD: implications for risk assessment.
    Keenan RE; Paustenbach DJ; Wenning RJ; Parsons AH
    J Toxicol Environ Health; 1991 Nov; 34(3):279-96. PubMed ID: 1942119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.